{
    "items": "50",
    "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
    "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
    "feed": [
        {
            "title": "TSMY Stock Fund Price and Chart \u2014 AMEX:TSMY",
            "url": "https://www.tradingview.com/symbols/AMEX-TSMY/",
            "time_published": "20260228T075232",
            "authors": [],
            "summary": "The TSMY fund, YieldMax TSM Option Income Strategy ETF, aims to generate monthly income and provide exposure to Taiwan Semiconductor Manufacturing (TSM) ADR price returns through a synthetic covered call strategy. It uses ETFs and FLEX options, involving synthetic long exposure, covered call writing, and US Treasuries. The fund does not directly invest in TSM stocks and has an expense ratio of 0.99% and a current indicated dividend yield of 49.23%.",
            "banner_image": "https://s3-symbol-logo.tradingview.com/yieldmax-tsla-option-income-strategy-etf--big.svg",
            "source": "TradingView",
            "category_within_source": "General",
            "source_domain": "TradingView",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.919351"
                }
            ],
            "overall_sentiment_score": 0.100315,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TSMY",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.142302",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "TSLW Stock Fund Price and Chart \u2014 CBOE:TSLW",
            "url": "https://www.tradingview.com/symbols/CBOE-TSLW/",
            "time_published": "20260228T075218",
            "authors": [],
            "summary": "The Roundhill TSLA WeeklyPay ETF (TSLW) aims to provide weekly income and enhanced exposure to TSLA stock's weekly price performance, utilizing total return swap agreements and TSLA common stock. The fund makes weekly distributions and invests in short-term US Treasurys, but introduces volatility due to its lack of diversification and leverage. TSLW launched on February 19, 2025, and has experienced significant price and NAV decreases since its inception.",
            "banner_image": "https://s3-symbol-logo.tradingview.com/roundhmetave-aeoa--big.svg",
            "source": "TradingView",
            "category_within_source": "General",
            "source_domain": "TradingView",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.939025"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.849773"
                }
            ],
            "overall_sentiment_score": -0.085688,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TSW",
                    "relevance_score": "0.306061",
                    "ticker_sentiment_score": "0.049765",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.891701",
                    "ticker_sentiment_score": "-0.337837",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "CBOE",
                    "relevance_score": "0.612018",
                    "ticker_sentiment_score": "0.118224",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "TSDD ETF Analysis: Dividends, Returns NASDAQ:TSDD",
            "url": "https://www.tradingview.com/symbols/NASDAQ-TSDD/analysis/",
            "time_published": "20260228T075213",
            "authors": [],
            "summary": "This article provides an analysis of the GraniteShares 2x Short TSLA Daily ETF (TSDD), detailing its objective to deliver -2x the daily price return of Tesla stock. It highlights key statistics such as its $55.91 million AUM, 7.61% dividend yield, and 0.95% expense ratio. The article also discusses its short-term tactical nature, risks due to lack of diversification, dividend history, and recent performance metrics.",
            "banner_image": null,
            "source": "TradingView",
            "category_within_source": "General",
            "source_domain": "TradingView",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "1.000000"
                }
            ],
            "overall_sentiment_score": -0.096546,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TSDD",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.036810",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.836987",
                    "ticker_sentiment_score": "-0.134148",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Henry Schein (NASDAQ:HSIC) Upgraded by Wall Street Zen to \"Strong-Buy\" Rating",
            "url": "https://www.marketbeat.com/instant-alerts/henry-schein-nasdaqhsic-upgraded-by-wall-street-zen-to-strong-buy-rating-2026-02-28/",
            "time_published": "20260228T074424",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Wall Street Zen has upgraded Henry Schein (NASDAQ:HSIC) from a \"buy\" to a \"strong-buy\" rating. This upgrade comes after the company reported strong Q4 earnings, beating analyst estimates for EPS and revenue, alongside a positive sentiment from several other analysts and hitting a new 12-month high. Despite a recent insider stock sale by the CEO, institutional investors show increased interest in the healthcare products and services distributor.",
            "banner_image": "https://www.marketbeat.com/logos/henry-schein-inc-logo-1200x675.jpg",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.916084"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.808760"
                },
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.725770"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.626714"
                }
            ],
            "overall_sentiment_score": 0.39398,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HSIC",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.396004",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Deere (DE) Margin Compression In Q1 2026 Tests Premium P/E Growth Narrative",
            "url": "https://simplywall.st/stocks/us/capital-goods/nyse-de/deere/news/deere-de-margin-compression-in-q1-2026-tests-premium-pe-grow",
            "time_published": "20260228T074402",
            "authors": [
                "Simply Wall St"
            ],
            "summary": "Deere (DE) reported Q1 2026 revenue of US$9.6 billion and EPS of US$2.43, with trailing 12-month net profit margins falling to 10.3% from 13% a year prior. Despite analyst expectations for 15.8% annual earnings growth, the declining profitability and softening profit relative to sales are raising questions about its premium 35.3x P/E ratio. Additionally, the company faces a red flag regarding its debt coverage by operating cash flow, suggesting potential financial resilience concerns amidst modest revenue growth.",
            "banner_image": "https://images.simplywall.st/company/aaea2ecf-c4c6-40d1-b0b5-d99254559a35/chart/revenue-and-expenses-breakdown?date=2026-02-28",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.928744"
                },
                {
                    "topic": "manufacturing",
                    "relevance_score": "0.738943"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.620552"
                }
            ],
            "overall_sentiment_score": -0.286786,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "DE",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.257736",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Telin Gandeng IPification, Hadirkan Mobile Network Verification untuk Autentikasi Aman Tanpa OTP",
            "url": "https://mettanews.id/telin-gandeng-ipification-hadirkan-mobile-network-verification-untuk-autentikasi-aman-tanpa-otp/",
            "time_published": "20260228T073942",
            "authors": [
                "Puspita"
            ],
            "summary": "PT Telekomunikasi Indonesia International (Telin) has partnered with IPification to launch Telin Mobile Network Verification (MNV), a digital identity solution for secure, instant, and seamless authentication without the need for OTPs. This solution leverages the cellular network as a digital trust foundation, expanding Telin's Telco API portfolio and addressing the growing demand for more secure and efficient authentication methods in the digital services industry. Telin MNV aims to provide stronger protection against phishing and account takeovers while offering new revenue streams for mobile operators.",
            "banner_image": "https://mettanews.id/wp-content/uploads/2026/02/IMG-20260228-WA0034.jpg",
            "source": "Mettanews.id",
            "category_within_source": "General",
            "source_domain": "Mettanews.id",
            "topics": [
                {
                    "topic": "technology",
                    "relevance_score": "0.904792"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.839045"
                }
            ],
            "overall_sentiment_score": 0.40528,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "TLK",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.449364",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Is It Time To Reassess THOR Industries (THO) After Recent Share Price Weakness",
            "url": "https://simplywall.st/stocks/us/automobiles/nyse-tho/thor-industries/news/is-it-time-to-reassess-thor-industries-tho-after-recent-shar",
            "time_published": "20260228T073625",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "This article evaluates THOR Industries (THO) following recent share price weakness, which saw the stock decline by 15.4% over 7 days and 14.1% over 30 days. Using Discounted Cash Flow (DCF) analysis and Price vs. Earnings (P/E) ratios, Simply Wall St assesses THO's valuation, concluding it appears modestly undervalued. The article suggests that while valuation is complex, these metrics offer a way for investors to determine if the stock presents a good buying opportunity.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/6YVpCWgrk0c9DenG6UgW8m/d79e37d527c71a95e08b9ce1071ba986/Image_from_iOS.jpg?fit=thumb&w=64&h=64",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.827104"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.949036"
                }
            ],
            "overall_sentiment_score": 0.300376,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "THO",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.348500",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Is Enphase Energy (ENPH) Pricing Look Attractive After Steep Three Year Share Price Fall",
            "url": "https://simplywall.st/stocks/us/semiconductors/nasdaq-enph/enphase-energy/news/is-enphase-energy-enph-pricing-look-attractive-after-steep-t",
            "time_published": "20260228T073610",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "This article evaluates Enphase Energy's (ENPH) current stock valuation after a significant price decline over the past three years. Using two different valuation methods\u2014Discounted Cash Flow (DCF) and Price-to-Earnings (P/E) ratio\u2014Simply Wall St provides conflicting results, with DCF suggesting overvaluation and P/E suggesting undervaluation. The piece also presents bull and bear case narratives from the community to offer a more nuanced perspective on the company's future value.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.920356"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.800350"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.711514"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.630335"
                }
            ],
            "overall_sentiment_score": 0.026197,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ENPH",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.001245",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Regeneron Pharmaceuticals (NASDAQ:REGN) Raised to \"Buy\" at Wall Street Zen",
            "url": "https://www.marketbeat.com/instant-alerts/regeneron-pharmaceuticals-nasdaqregn-raised-to-buy-at-wall-street-zen-2026-02-28/",
            "time_published": "20260228T073558",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Wall Street Zen has upgraded Regeneron Pharmaceuticals (NASDAQ:REGN) from a \"hold\" to a \"buy\" rating, reflecting a broader positive sentiment from analysts with an average target price of $793.81, indicating a \"Moderate Buy\" consensus. This upgrade follows Regeneron's strong quarterly earnings, where they surpassed analyst expectations for both EPS and revenue, demonstrating a 2.5% year-over-year revenue increase. Despite recent insider selling, institutional ownership remains high, underscoring confidence in the biopharmaceutical company's performance.",
            "banner_image": "https://www.marketbeat.com/logos/regeneron-pharmaceuticals-inc-logo-1200x675.png?v=20221021082404",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.944900"
                },
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.854572"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.754058"
                }
            ],
            "overall_sentiment_score": 0.318261,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "REGN",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.522293",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.614689",
                    "ticker_sentiment_score": "0.134801",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Here\u2019s What Analysts Are Saying About Vertex Pharmaceuticals (VRTX)",
            "url": "https://www.insidermonkey.com/blog/heres-what-analysts-are-saying-about-vertex-pharmaceuticals-vrtx-1705809/",
            "time_published": "20260228T073016",
            "authors": [
                "Noor Ul Ain Rehman"
            ],
            "summary": "Analysts have issued updated ratings and price targets for Vertex Pharmaceuticals (VRTX) following its fiscal Q4 and full-year 2025 earnings report. Canaccord maintained a Hold rating and raised its price target to $441, while Barclays maintained an Overweight rating with a price target of $607. H.C. Wainwright reaffirmed a Buy rating, increasing its price target to $591, due to optimism about its pipeline.",
            "banner_image": "https://imonkey-blog.imgix.net/blog/wp-content/uploads/2023/09/23110749/VRTX-insidermonkey-1695481667836.jpg?auto=format&fit=clip&expires=2082758400&width=480&height=269",
            "source": "Insider Monkey",
            "category_within_source": "General",
            "source_domain": "Insider Monkey",
            "topics": [
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.936875"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.935603"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.717514"
                }
            ],
            "overall_sentiment_score": 0.445218,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.978358",
                    "ticker_sentiment_score": "0.425057",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds",
            "url": "https://finviz.com/news/325967/why-regeneron-pharmaceuticals-regn-is-one-of-the-top-gene-therapy-stocks-to-buy-according-to-hedge-funds",
            "time_published": "20260228T072958",
            "authors": [
                "Noor Ul Ain Rehman"
            ],
            "summary": "Regeneron Pharmaceuticals (REGN) is highlighted as a top gene therapy stock favored by hedge funds, following recent FDA approvals for its treatments. The company received approval for Dupixent to treat allergic fungal rhinosinusitis and FDA acceptance for Priority Review of garetosmab for fibrodysplasia ossificans progressiva. Despite these positive developments, the article suggests that certain AI stocks may offer greater upside potential with less risk.",
            "banner_image": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/23055613/REGN-insidermonkey-1695462971092.jpg",
            "source": "Finviz",
            "category_within_source": "General",
            "source_domain": "Finviz",
            "topics": [
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.908590"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.814177"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.700701"
                }
            ],
            "overall_sentiment_score": 0.622268,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "REGN",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.636158",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "BofA Lifts PT on Apollo Global Management (APO) to $167 From $161 \u2013 Here\u2019s Why",
            "url": "https://www.insidermonkey.com/blog/bofa-lifts-pt-on-apollo-global-management-apo-to-167-from-161-heres-why-1705893/",
            "time_published": "20260228T072843",
            "authors": [
                "Noor Ul Ain Rehman"
            ],
            "summary": "BofA upgraded Apollo Global Management's (APO) price target to $167 from $161, reiterating a Buy rating, due to revised EPS estimates. This comes after RBC Capital initiated coverage with a Sector Perform rating and a $142 target, citing valuation. Additionally, Apollo-managed funds invested $1 billion in Aldar Properties PJSC, increasing their aggregate commitments to $2.9 billion in the UAE-based real estate developer.",
            "banner_image": "https://imonkey-blog.imgix.net/blog/wp-content/uploads/2023/09/21090424/APO-insidermonkey-1695301462944.jpg?auto=format&fit=clip&expires=2082758400&width=480&height=269",
            "source": "Insider Monkey",
            "category_within_source": "General",
            "source_domain": "Insider Monkey",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.922839"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.809668"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.744593"
                },
                {
                    "topic": "real_estate",
                    "relevance_score": "0.636824"
                }
            ],
            "overall_sentiment_score": 0.432274,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "APO",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.442917",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Is Taseko Mines (TSX:TKO) Turning Higher 2026 Copper Guidance Into a Durable Profit Engine?",
            "url": "https://simplywall.st/stocks/ca/materials/tsx-tko/taseko-mines-shares/news/is-taseko-mines-tsxtko-turning-higher-2026-copper-guidance-i",
            "time_published": "20260228T072830",
            "authors": [
                "Simply Wall St",
                "Sasha Jovanovic"
            ],
            "summary": "Taseko Mines (TSX:TKO) reported its 2025 financial results, including a net loss despite record revenues and solid adjusted EBITDA. The company issued higher 2026 copper production guidance, supported by progress at the Connector pit and initial output from Florence Copper, and management forecasts additional 2026 copper output from Florence. The core challenge for Taseko remains translating increased production volumes into consistent profitability and improved financial health, with analysts projecting significant revenue and earnings growth by 2028.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.916395"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.734913"
                }
            ],
            "overall_sentiment_score": 0.087426,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TGB",
                    "relevance_score": "0.342270",
                    "ticker_sentiment_score": "0.031019",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TKO",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.130419",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Invesco (NYSE:IVZ) Stock Rating Lowered by Wall Street Zen",
            "url": "https://www.marketbeat.com/instant-alerts/invesco-nyseivz-stock-rating-lowered-by-wall-street-zen-2026-02-28/",
            "time_published": "20260228T072828",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Wall Street Zen has downgraded Invesco (NYSE:IVZ) from a \"buy\" to a \"hold\" rating, maintaining a consensus \"Hold\" with a target price of $28.46. Despite beating recent earnings estimates with an EPS of $0.62 and revenue of $1.26 billion, the company still reported a negative net margin of -6.92%. Invesco's stock opened at $26.26, showing a 3.1% decline, and has a market capitalization of approximately $11.7 billion.",
            "banner_image": "https://www.marketbeat.com/logos/invesco-ltd-logo-1200x675.jpg?v=20240216124910",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.911651"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.844403"
                }
            ],
            "overall_sentiment_score": -0.046297,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "IVZ",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.206671",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "BLK",
                    "relevance_score": "0.743305",
                    "ticker_sentiment_score": "0.039024",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.641256",
                    "ticker_sentiment_score": "0.138699",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Halliburton (NYSE:HAL) Lowered to \"Buy\" Rating by Wall Street Zen",
            "url": "https://www.marketbeat.com/instant-alerts/halliburton-nysehal-lowered-to-buy-rating-by-wall-street-zen-2026-02-28/",
            "time_published": "20260228T072821",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Wall Street Zen has downgraded Halliburton (NYSE:HAL) from a \"strong-buy\" to a \"buy\" rating. Despite the downgrade, several brokerages have increased their price targets for HAL, leading to a consensus \"Moderate Buy\" rating with an average target of $35.19. The company also surpassed Q4 earnings and revenue estimates, though insiders sold a significant number of shares.",
            "banner_image": "https://www.marketbeat.com/logos/halliburton-logo-1200x675.png?v=20240104073205",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.919366"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.825889"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.717993"
                }
            ],
            "overall_sentiment_score": 0.126238,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HAL",
                    "relevance_score": "0.345979",
                    "ticker_sentiment_score": "0.022623",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.646544",
                    "ticker_sentiment_score": "0.265647",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.562599",
                    "ticker_sentiment_score": "0.109471",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Booking Holdings Inc. (BKNG) is One of the Best Cheap Blue Chip Stocks to Buy According to Analysts",
            "url": "https://www.insidermonkey.com/blog/why-booking-holdings-inc-bkng-is-one-of-the-best-cheap-blue-chip-stocks-to-buy-according-to-analysts-1705897/",
            "time_published": "20260228T072550",
            "authors": [
                "Noor Ul Ain Rehman"
            ],
            "summary": "Booking Holdings Inc. (BKNG) is considered one of the best cheap blue-chip stocks by analysts, receiving Buy and Overweight ratings from JPMorgan and Morgan Stanley, respectively. Analysts maintain high price targets, citing the company's strong position in the travel sector, robust traveler data, and direct business model, even with the evolution of agentic travel tools. Susquehanna also raised its price target, highlighting sound fiscal performance and continued investment in the business, despite potential for short-term volatility.",
            "banner_image": "https://imonkey-blog.imgix.net/blog/wp-content/uploads/2023/09/20062800/BKNG-insidermonkey-1695205677150.jpg?auto=format&fit=clip&expires=2082758400&width=480&height=269",
            "source": "Insider Monkey",
            "category_within_source": "General",
            "source_domain": "Insider Monkey",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.936397"
                },
                {
                    "topic": "retail_wholesale",
                    "relevance_score": "0.742747"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.646506"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.825840"
                }
            ],
            "overall_sentiment_score": 0.41718,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BKNG",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.401514",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Here's What Analysts Are Saying About PG&E Corporation (PCG)",
            "url": "https://finviz.com/news/325947/heres-what-analysts-are-saying-about-pge-corporation-pcg",
            "time_published": "20260228T071950",
            "authors": [
                "Noor Ul Ain Rehman"
            ],
            "summary": "Analysts from Morgan Stanley and UBS have updated their price targets for PG&E Corporation (PCG) following the company's Q4 and full-year 2025 earnings report. Morgan Stanley raised its price target to $23 from $21, while UBS lifted its target to $20 from $18. The company reported improved non-GAAP core earnings for both the quarter and the full year, and specializes in utility, electricity, energy, power, solar, gas, and sustainability.",
            "banner_image": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/23134012/PCG-insidermonkey-1695490809704.jpg",
            "source": "Finviz",
            "category_within_source": "General",
            "source_domain": "Finviz",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.937620"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.815454"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.726058"
                }
            ],
            "overall_sentiment_score": 0.333995,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PCG",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.340722",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Where is UnitedHealth Group Incorporated (UNH) Headed?",
            "url": "https://finviz.com/news/325948/where-is-unitedhealth-group-incorporated-unh-headed",
            "time_published": "20260228T071914",
            "authors": [
                "Noor Ul Ain Rehman"
            ],
            "summary": "UnitedHealth Group Incorporated (UNH) recently announced a cash dividend of $2.21 per share. Despite being considered a top cheap blue-chip stock by analysts, firms like Mizuho, Truist, and JPMorgan have cut its price target, citing pushed-out earnings recovery and adjusting estimates post-Q4 results and 2026 guidance. The article suggests that while UNH has potential, some AI stocks may offer greater upside and less risk.",
            "banner_image": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/19161417/UNH-insidermonkey-1695154454514.jpg",
            "source": "Finviz",
            "category_within_source": "General",
            "source_domain": "Finviz",
            "topics": [
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.946659"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.827725"
                }
            ],
            "overall_sentiment_score": 0.026138,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "UNH",
                    "relevance_score": "0.332054",
                    "ticker_sentiment_score": "0.033493",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cisco Systems (NASDAQ:CSCO) Upgraded by Wall Street Zen to Buy Rating",
            "url": "https://www.marketbeat.com/instant-alerts/cisco-systems-nasdaqcsco-upgraded-by-wall-street-zen-to-buy-rating-2026-02-28/",
            "time_published": "20260228T071000",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Wall Street Zen has upgraded Cisco Systems (NASDAQ:CSCO) to a \"buy\" rating, with a consensus price target of $89.55 from analysts. The upgrade follows Cisco beating quarterly earnings and revenue estimates. However, recent insider selling and the disclosure of a critical security bug exploited by hackers present potential near-term risks for the company.",
            "banner_image": "https://www.marketbeat.com/logos/cisco-systems-inc-logo-1200x675.jpg",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.948666"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.922292"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.847834"
                }
            ],
            "overall_sentiment_score": 0.062909,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CSCO",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.247927",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.615358",
                    "ticker_sentiment_score": "0.237179",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.566830",
                    "ticker_sentiment_score": "0.206749",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JBL",
                    "relevance_score": "0.564133",
                    "ticker_sentiment_score": "-0.111512",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.615789",
                    "ticker_sentiment_score": "-0.345957",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Cooper Companies (NASDAQ:COO) Raised to \"Buy\" at Wall Street Zen",
            "url": "https://www.marketbeat.com/instant-alerts/cooper-companies-nasdaqcoo-raised-to-buy-at-wall-street-zen-2026-02-28/",
            "time_published": "20260228T070958",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Wall Street Zen has upgraded Cooper Companies (COO) from a \"hold\" to a \"buy\" rating, contributing to a \"Moderate Buy\" consensus among analysts with an average price target of $90.77. The company recently surpassed Q4 earnings expectations, reporting EPS of $1.15 and $1.07 billion in revenue, and provided optimistic guidance for FY2026 and Q1. Insider buying, including a significant purchase by CEO Albert G. White III, further signals management's confidence in the company's prospects.",
            "banner_image": "https://www.marketbeat.com/logos/cooper-companies-inc-logo-1200x675.png?v=20200617151750",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.920321"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.823979"
                },
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.715796"
                }
            ],
            "overall_sentiment_score": 0.303541,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "COO",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.303322",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Cummins (NYSE:CMI) Upgraded to \"Strong-Buy\" at Wall Street Zen",
            "url": "https://www.marketbeat.com/instant-alerts/cummins-nysecmi-upgraded-to-strong-buy-at-wall-street-zen-2026-02-28/",
            "time_published": "20260228T070954",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Wall Street Zen has upgraded Cummins (NYSE:CMI) from a \"buy\" to a \"strong-buy\" rating. This upgrade comes after Cummins reported strong quarterly earnings, beating EPS and revenue expectations. The article also details recent insider selling, institutional investor holdings, and the company's financial performance metrics.",
            "banner_image": "https://www.marketbeat.com/logos/cummins-inc-logo-1200x675.png?v=20231228134629",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.908633"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.832761"
                },
                {
                    "topic": "manufacturing",
                    "relevance_score": "0.723409"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.611172"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.637072"
                }
            ],
            "overall_sentiment_score": 0.47367,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CMI",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.477135",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Rep. Josh Gottheimer Sells Off Shares of Uber Technologies, Inc. (NYSE:UBER)",
            "url": "https://www.marketbeat.com/instant-alerts/rep-josh-gottheimer-sells-off-shares-of-uber-technologies-inc-nyseuber-2026-02-28/",
            "time_published": "20260228T070423",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Rep. Josh Gottheimer recently sold between $1,001 and $15,000 worth of Uber Technologies (NYSE:UBER) stock on January 30th. This sale occurred despite a significant insider purchase by Uber CFO Balaji Krishnamurthy, who bought $1.6 million in shares on February 24th. Uber missed its quarterly EPS estimate with $0.71 versus $0.79, although revenue grew by 20.1% year-over-year, supported by growth initiatives and positive analyst coverage.",
            "banner_image": "https://www.marketbeat.com/logos/uber-technologies-inc-logo-1200x675.png?v=20191127154752",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.926473"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.919126"
                },
                {
                    "topic": "economy_fiscal",
                    "relevance_score": "0.609566"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.737562"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.821386"
                }
            ],
            "overall_sentiment_score": 0.100234,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "UBER",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.267687",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NOW",
                    "relevance_score": "0.629479",
                    "ticker_sentiment_score": "0.128951",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "APD",
                    "relevance_score": "0.569002",
                    "ticker_sentiment_score": "-0.149630",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Ball Corporation (NYSE:BALL) Given Consensus Rating of \"Moderate Buy\" by Brokerages",
            "url": "https://www.marketbeat.com/instant-alerts/ball-corporation-nyseball-given-consensus-rating-of-moderate-buy-by-brokerages-2026-02-28/",
            "time_published": "20260228T065945",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Ball Corporation (NYSE:BALL) has received a consensus \"Moderate Buy\" rating from fourteen brokerage firms, with an average price target of $68.46. The company recently surpassed Q4 earnings and revenue estimates and provided strong FY2026 guidance. Institutional investors hold a significant portion of BALL shares, and the company offers a quarterly dividend.",
            "banner_image": "https://www.marketbeat.com/logos/ball-corp-logo-1200x675.jpg?v=20220511075000",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.943906"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.822937"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.722254"
                },
                {
                    "topic": "manufacturing",
                    "relevance_score": "0.621513"
                }
            ],
            "overall_sentiment_score": 0.498055,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BALL",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.467270",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "US Paralympian partners with Autodesk to advance high-performance prosthetics",
            "url": "https://www.todaysmedicaldevelopments.com/news/us-paralympian-partners-with-autodesk-advance-high-performance-prosthetics/",
            "time_published": "20260228T065936",
            "authors": [
                "Clare Scott"
            ],
            "summary": "Three-time U.S. Paralympic medalist Mike Schultz, founder and CEO of BioDapt, is partnering with Autodesk to develop next-generation prosthetics for para athletes. Schultz, who is retiring from competitive para snowboarding, will leverage Autodesk's Fusion platform to scale innovation across winter and summer para sports. This collaboration aims to improve prosthetic design, durability, and accessibility, moving beyond elite competition to benefit a wider population in need of assistive products.",
            "banner_image": "https://www.todaysmedicaldevelopments.com/remote/aHR0cHM6Ly9naWVjZG4uYmxvYi5jb3JlLndpbmRvd3MubmV0L2ZpbGV1cGxvYWRzL2ltYWdlLzIwMjYvMDIvMjQvYWRza19ib3N0b25fdGVjaF9jZW50ZXJfMl93b3JkbWFyay5qcGc.CVl1zumllqw.jpg?format=webp",
            "source": "Today's Medical Developments",
            "category_within_source": "General",
            "source_domain": "Today's Medical Developments",
            "topics": [
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.940990"
                },
                {
                    "topic": "manufacturing",
                    "relevance_score": "0.941520"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.822058"
                }
            ],
            "overall_sentiment_score": 0.472218,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ADSK",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.477195",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "TJGC Stock Price and Chart \u2014 NASDAQ:TJGC",
            "url": "https://www.tradingview.com/symbols/NASDAQ-TJGC/",
            "time_published": "20260228T065312",
            "authors": [],
            "summary": "This article provides a detailed overview of TJGC Group Limited (NASDAQ: TJGC) stock performance, key financial metrics, and company information. It includes current stock price, historical performance data, market capitalization, revenue, net income, and employee count. Additionally, it offers technical analysis indicators and answers frequently asked questions about the company's stock.",
            "banner_image": "https://s3-symbol-logo.tradingview.com/ctrl-limited--big.svg",
            "source": "TradingView",
            "category_within_source": "General",
            "source_domain": "TradingView",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.947160"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.835187"
                },
                {
                    "topic": "ipo",
                    "relevance_score": "0.744844"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.644445"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.630125"
                }
            ],
            "overall_sentiment_score": -0.22264,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "TJGC",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.201188",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Ball Corp Stock After Aerospace Sale: Buy the Packaging Pivot or Wait?",
            "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/ball-corp-stock-after-aerospace-sale-buy-the-packaging-pivot-or-wait/68620226",
            "time_published": "20260228T065245",
            "authors": [],
            "summary": "Ball Corp has transformed into a pure-play packaging company after selling its aerospace division to BAE Systems, a move that significantly changes its investment profile and financial outlook. This strategic pivot means the company's performance is now tightly linked to consumer beverage demand, aluminum costs, and sustainability trends rather than defense budgets. Investors should monitor how Ball manages its strengthened balance sheet, capital allocation, and ability to execute on cost controls and pricing power within the packaging sector.",
            "banner_image": null,
            "source": "AD HOC NEWS",
            "category_within_source": "General",
            "source_domain": "AD HOC NEWS",
            "topics": [
                {
                    "topic": "mergers_and_acquisitions",
                    "relevance_score": "0.814162"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.913589"
                },
                {
                    "topic": "manufacturing",
                    "relevance_score": "0.714363"
                },
                {
                    "topic": "economy_macro",
                    "relevance_score": "0.704730"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.801666"
                }
            ],
            "overall_sentiment_score": 0.018349,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BALL",
                    "relevance_score": "0.304356",
                    "ticker_sentiment_score": "0.019547",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Entrada Therapeutics (NASDAQ:TRDA) Stock Rating Upgraded by Wall Street Zen",
            "url": "https://www.marketbeat.com/instant-alerts/entrada-therapeutics-nasdaqtrda-stock-rating-upgraded-by-wall-street-zen-2026-02-28/",
            "time_published": "20260228T065238",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Wall Street Zen has upgraded Entrada Therapeutics (NASDAQ:TRDA) from a \"sell\" to a \"hold\" rating, contributing to a \"Moderate Buy\" consensus among analysts with an average target price of $18.50. Despite beating EPS expectations last quarter, the company significantly missed revenue targets and displays deeply negative net margins. Institutional ownership remains high at 86.39%, with several major hedge funds increasing or initiating positions.",
            "banner_image": "https://www.marketbeat.com/logos/entrada-therapeutics-inc-logo-1200x675.png?v=20211207110350",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.922403"
                },
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.803761"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.712068"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.645137"
                }
            ],
            "overall_sentiment_score": 0.147075,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TRDA",
                    "relevance_score": "0.954354",
                    "ticker_sentiment_score": "0.280281",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.624675",
                    "ticker_sentiment_score": "0.118474",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.566375",
                    "ticker_sentiment_score": "0.085324",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "SSTK Financials: Income Statement, Balance Sheet & Cash Flow",
            "url": "https://www.stocktitan.net/financials/SSTK/",
            "time_published": "20260228T065227",
            "authors": [],
            "summary": "This article provides a detailed financial analysis of Shutterstock Inc. (SSTK), including its income statement, balance sheet, and cash flow statement up to fiscal year 2025. It highlights key financial health signals such as profitability (moderate operating margin), growth (solid revenue increase), leverage (low debt-to-equity), liquidity (tight current ratio), cash flow (moderate margin), and returns (moderate ROE). The analysis also includes metrics like Altman Z-Score, Piotroski F-Score, and earnings quality, offering a comprehensive overview of the company's financial performance and risks.",
            "banner_image": null,
            "source": "Stock Titan",
            "category_within_source": "General",
            "source_domain": "Stock Titan",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.912287"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.829223"
                }
            ],
            "overall_sentiment_score": 0.261148,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SSTK",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.295154",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Swvl Holdings (Nasdaq:SWVL) - Stock Analysis",
            "url": "https://simplywall.st/stocks/us/transportation/nasdaq-swvl/swvl-holdings",
            "time_published": "20260228T065225",
            "authors": [],
            "summary": "This article provides a stock analysis of Swvl Holdings (Nasdaq:SWVL), a technology-driven disruptive mobility company. It covers the company's financial performance, recent news and updates, shareholder returns, and key fundamentals such as market cap, earnings, and revenue. The analysis highlights the company's volatile share price and underperformance compared to the US transportation industry and market.",
            "banner_image": "https://images.simplywall.st/asset/industry/8041000-choice1-dashboard-thumb/1588563527630",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.919241"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.924303"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.710601"
                }
            ],
            "overall_sentiment_score": -0.239785,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "SWVL",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.201037",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "SRG - Seritage Growth Pptys Latest Stock News & Market Updates",
            "url": "https://www.stocktitan.net/news/SRG/page-7.html",
            "time_published": "20260228T065220",
            "authors": [],
            "summary": "This page provides investors and traders with the latest news and insights on Seritage Growth Properties (SRG) stock, a real estate company focused on redeveloping retail and mixed-use properties. The news feed covers the company's Plan of Sale, asset sales, leasing milestones, and financial results, including net loss, operating income, and capital structure management. It highlights how these activities impact their Class A common shares and 7.00% Series A cumulative redeemable preferred shares.",
            "banner_image": null,
            "source": "Stock Titan",
            "category_within_source": "General",
            "source_domain": "Stock Titan",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.918281"
                },
                {
                    "topic": "real_estate",
                    "relevance_score": "0.914501"
                }
            ],
            "overall_sentiment_score": -0.242624,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "SRG",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.243917",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "SPD Stock Fund Price and Chart \u2014 AMEX:SPD",
            "url": "https://www.tradingview.com/symbols/AMEX-SPD/",
            "time_published": "20260228T065157",
            "authors": [],
            "summary": "The Simplify US Equity PLUS Downside Convexity ETF (SPD) is an actively managed fund that aims for capital appreciation by investing primarily in S&P 500 ETFs with a modest put option overlay. This strategy is designed to offer downside protection without capping upside potential, achieving downside convexity. The fund, launched on September 3, 2020, has assets under management of $114.78 million and an expense ratio of 0.53%.",
            "banner_image": "https://s3-symbol-logo.tradingview.com/simplify-exchange-traded-funds--big.svg",
            "source": "TradingView",
            "category_within_source": "General",
            "source_domain": "TradingView",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.936797"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.817369"
                },
                {
                    "topic": "economy_macro",
                    "relevance_score": "0.631030"
                }
            ],
            "overall_sentiment_score": 0.091691,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SPD",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.067561",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "MAX S&P 500 4x Leveraged ETN (XXXX) Chart and Price History 2026 $XXXX",
            "url": "https://www.marketbeat.com/stocks/NYSEARCA/XXXX/chart/",
            "time_published": "20260228T065137",
            "authors": [],
            "summary": "This article provides the chart and price history for the MAX S&P 500 4x Leveraged ETN (XXXX) for 2026. It details the fund's performance over various timeframes, showing a significant decrease in price across the last 12 months, year-to-date, and in the past month. The report also includes daily price, volume, and market capitalization data up to February 27, 2026.",
            "banner_image": null,
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "1.000000"
                }
            ],
            "overall_sentiment_score": -0.548898,
            "overall_sentiment_label": "Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "SPYU",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.547662",
                    "ticker_sentiment_label": "Bearish"
                }
            ]
        },
        {
            "title": "Is Strong 2025 Earnings and a Completed Buyback Altering The Investment Case For Vulcan Materials (VMC)?",
            "url": "https://simplywall.st/stocks/us/materials/nyse-vmc/vulcan-materials/news/is-strong-2025-earnings-and-a-completed-buyback-altering-the/amp",
            "time_published": "20260228T065117",
            "authors": [
                "Simply Wall St"
            ],
            "summary": "Vulcan Materials Company reported strong full-year 2025 results with sales of US$7,941.1 million and net income of US$1,076.7 million, coupled with ongoing share repurchases. These results, along with the completion of a buyback program, emphasize management's dedication to shareholder returns and capital efficiency. The article suggests that while 2025 earnings beat expectations, the investment narrative for VMC remains tied to infrastructure spending and potential risks like weather volatility.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.949282"
                },
                {
                    "topic": "real_estate",
                    "relevance_score": "0.602935"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.618581"
                }
            ],
            "overall_sentiment_score": 0.331672,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "VMC",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.306945",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "How Low Can Texas Instruments Stock Really Go?",
            "url": "https://www.trefis.com/stock/txn/articles2/591811/how-low-can-texas-instruments-stock-really-go/2026-02-28",
            "time_published": "20260228T065113",
            "authors": [
                "Trefis Team"
            ],
            "summary": "This article analyzes the potential downside resilience of Texas Instruments (TXN) stock, especially considering past economic downturns. While TXN's Q4 earnings miss was offset by bullish Q1 guidance, the analysis reveals that TXN stock has historically seen impacts slightly worse than the S&P 500 during crises but has demonstrated strong recovery capabilities, though recovery times varied. Investors are encouraged to consider a portfolio approach due to the unpredictability of individual stocks.",
            "banner_image": "https://s3.amazonaws.com/wp-uploads-trefis/articles/wp-content/uploads/2025/09/30062457/How-Low-Can-It-Go-300x200.png",
            "source": "Trefis",
            "category_within_source": "General",
            "source_domain": "Trefis",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.938557"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.909871"
                },
                {
                    "topic": "economy_macro",
                    "relevance_score": "0.643280"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.832696"
                },
                {
                    "topic": "manufacturing",
                    "relevance_score": "0.604248"
                }
            ],
            "overall_sentiment_score": 0.078188,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TXN",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.173757",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "FSLR",
                    "relevance_score": "0.679309",
                    "ticker_sentiment_score": "0.145230",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MU",
                    "relevance_score": "0.626233",
                    "ticker_sentiment_score": "0.344100",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.528616",
                    "ticker_sentiment_score": "0.022787",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Would You Still Hold Micron Technology Stock If It Fell Another 30%?",
            "url": "https://www.trefis.com/stock/mu/articles2/591810/would-you-still-hold-micron-technology-stock-if-it-fell-another-30-2/2026-02-28",
            "time_published": "20260228T065046",
            "authors": [
                "Trefis Team"
            ],
            "summary": "Micron Technology (MU) stock has recently fallen 5.3%, prompting concerns about its resilience to further downturns amidst rising HBM competition and oversupply risks. The article analyzes MU's performance during past economic crises, showing it consistently underperformed the S&P 500 in terms of initial decline but eventually recovered. Despite strong current operational performance, its high valuation suggests potential vulnerability to a deeper market correction.",
            "banner_image": "https://s3.amazonaws.com/wp-uploads-trefis/articles/wp-content/uploads/2025/09/30062457/How-Low-Can-It-Go-300x200.png",
            "source": "Trefis",
            "category_within_source": "General",
            "source_domain": "Trefis",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.948866"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.823429"
                }
            ],
            "overall_sentiment_score": -0.058535,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MU",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.045014",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.636872",
                    "ticker_sentiment_score": "-0.128966",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Strong 2025 Earnings and a Completed Buyback Altering The Investment Case For Vulcan Materials (VMC)?",
            "url": "https://simplywall.st/stocks/us/materials/nyse-vmc/vulcan-materials/news/is-strong-2025-earnings-and-a-completed-buyback-altering-the",
            "time_published": "20260228T064824",
            "authors": [
                "Simply Wall St",
                "Sasha Jovanovic"
            ],
            "summary": "Vulcan Materials Company (VMC) recently announced strong full-year 2025 results, with substantial sales and net income, coupled with the completion of a significant share buyback program. While these results reinforce management's focus on shareholder returns and capital efficiency, the core investment case for VMC remains tied to the pace of US infrastructure spending and the risks associated with weather volatility and project delays. The article suggests exploring further analysis to understand how these factors influence Vulcan's future outlook and fair value.",
            "banner_image": "https://images.simplywall.st/company/b5c73fc4-1c78-42f4-b741-436f7057bd54/chart/quote-price",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.913134"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.830637"
                },
                {
                    "topic": "economy_macro",
                    "relevance_score": "0.738589"
                },
                {
                    "topic": "real_estate",
                    "relevance_score": "0.739429"
                }
            ],
            "overall_sentiment_score": 0.31243,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "VMC",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.406975",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MLM",
                    "relevance_score": "0.603746",
                    "ticker_sentiment_score": "0.246219",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Is Textron\u2019s New Shelf Filing and 2026 Guidance Altering The Investment Case For Textron (TXT)?",
            "url": "https://simplywall.st/stocks/us/capital-goods/nyse-txt/textron/news/is-textrons-new-shelf-filing-and-2026-guidance-altering-the",
            "time_published": "20260228T064817",
            "authors": [
                "Simply Wall St",
                "Sasha Jovanovic"
            ],
            "summary": "Textron recently announced a quarterly dividend and an omnibus shelf registration, alongside new 2026 guidance. This article examines how these updates, including 2026 revenue and earnings forecasts of about US$15.5 billion and US$6.40 to US$6.60 per share, impact Textron's investment narrative and risk-reward profile, especially concerning its financial flexibility and capital allocation priorities. It also highlights that some analysts had more cautious revenue growth projections, leading to differing conclusions about future opportunities and risks for the company.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/2zXqBK9eFqVJCGTQWhQWFX/c3400470ed0819d8056c9b1de6e897a0/Sasha_Jovanovic_-_Equity_Analyst.jpg?fit=thumb&w=64&h=64",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.900791"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.808571"
                },
                {
                    "topic": "manufacturing",
                    "relevance_score": "0.705348"
                }
            ],
            "overall_sentiment_score": 0.10376,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TXT",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.127449",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.563871",
                    "ticker_sentiment_score": "0.076160",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RTX",
                    "relevance_score": "0.560505",
                    "ticker_sentiment_score": "0.088959",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Royal Caribbean Expands Caribbean Routes And Premium Antarctica Offerings For Investors",
            "url": "https://simplywall.st/stocks/us/consumer-services/nyse-rcl/royal-caribbean-cruises/news/royal-caribbean-expands-caribbean-routes-and-premium-antarct",
            "time_published": "20260228T064801",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "Royal Caribbean (NYSE:RCL) has expanded its Caribbean itineraries for 2027-2028 and launched new private destinations, while its Silversea brand opened a bespoke hotel in Chile to support its Antarctica Fly Cruise program. These moves reflect a broader industry trend towards curated experiences and premium adventure travel. Investors should monitor how these new offerings impact guest reception, the allocation of capital between mass market and premium segments, and the company's high debt level in funding these developments.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/6YVpCWgrk0c9DenG6UgW8m/d79e37d527c71a95e08b9ce1071ba986/Image_from_iOS.jpg?fit=thumb&w=64&h=64",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.931970"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.827059"
                },
                {
                    "topic": "economy_macro",
                    "relevance_score": "0.642280"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.711141"
                }
            ],
            "overall_sentiment_score": 0.477065,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "RCL",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.509230",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Mosaic (MOS) Is Down 5.4% After Q4 Loss Highlights Profit Squeeze Amid Cost-Cutting Pivot",
            "url": "https://simplywall.st/stocks/us/materials/nyse-mos/mosaic/news/mosaic-mos-is-down-54-after-q4-loss-highlights-profit-squeez",
            "time_published": "20260228T064744",
            "authors": [
                "Simply Wall St",
                "Sasha Jovanovic"
            ],
            "summary": "The Mosaic Company (MOS) reported a net loss of US$519.5 million and diluted loss per share of US$1.64 in Q4 2025, leading to a 5.4% stock price drop. The loss was attributed to weaker U.S. phosphate demand and delayed government support, despite increased full-year sales and ongoing cost-cutting efforts. Management plans further cost reductions and higher phosphate and potash production in 2026 to improve margins and balance sheet strength.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/2zXqBK9eFqVJCGTQWhQWFX/c3400470ed0819d8056c9b1de6e897a0/Sasha_Jovanovic_-_Equity_Analyst.jpg?fit=thumb&w=64&h=64",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.934713"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.838618"
                }
            ],
            "overall_sentiment_score": -0.223954,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "MOS",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.236526",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Sociedad Quimica y Minera S.A. (NYSE:SQM) Receives Average Rating of \"Moderate Buy\" from Brokerages",
            "url": "https://www.marketbeat.com/instant-alerts/sociedad-quimica-y-minera-sa-nysesqm-receives-average-rating-of-moderate-buy-from-brokerages-2026-02-28/",
            "time_published": "20260228T064355",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Sociedad Quimica y Minera S.A. (NYSE:SQM) has received an average rating of \"Moderate Buy\" from fourteen brokerages, with an average 12-month price target of $69.7917. Several analysts have recently updated their ratings and price targets, including upgrades from Scotiabank and Zacks Research, and an increase in price target from JPMorgan Chase & Co. The company also recently announced a special dividend.",
            "banner_image": "https://www.marketbeat.com/logos/sociedad-qu\u00edmica-y-minera-de-chile-sa-logo-1200x675.png?v=20240102162738",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.930314"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.811947"
                }
            ],
            "overall_sentiment_score": 0.037297,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SQM",
                    "relevance_score": "0.346176",
                    "ticker_sentiment_score": "0.018653",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Tarsus Pharmaceuticals (NASDAQ:TARS) Downgraded to Hold Rating by Wall Street Zen",
            "url": "https://www.marketbeat.com/instant-alerts/tarsus-pharmaceuticals-nasdaqtars-downgraded-to-hold-rating-by-wall-street-zen-2026-02-28/",
            "time_published": "20260228T064024",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Wall Street Zen downgraded Tarsus Pharmaceuticals (NASDAQ:TARS) from \"buy\" to \"hold,\" contributing to a mixed analyst outlook despite a consensus \"Moderate Buy\" rating with an $87 target. The company's Q4 revenue of $151.7 million exceeded estimates, but EPS slightly missed, and it remains unprofitable with negative margins. Insider stock sales and significant institutional ownership were also noted.",
            "banner_image": "https://www.marketbeat.com/logos/tarsus-pharmaceuticals-inc-logo-1200x675.PNG?v=20201222141100",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.934698"
                },
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.801250"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.721460"
                }
            ],
            "overall_sentiment_score": -0.292262,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "TARS",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.265004",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Talkspace (NASDAQ:TALK) Upgraded by Wall Street Zen to \"Strong-Buy\" Rating",
            "url": "https://www.marketbeat.com/instant-alerts/talkspace-nasdaqtalk-upgraded-by-wall-street-zen-to-strong-buy-rating-2026-02-28/",
            "time_published": "20260228T064006",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Wall Street Zen has upgraded Talkspace (NASDAQ:TALK) to a \"strong-buy\" rating, despite mixed analyst sentiment that averages to a \"Moderate Buy\" with a $5.13 price target. The company recently surpassed earnings and revenue expectations, reporting $0.03 EPS and $63.0M in revenue, and has a market cap of approximately $798 million. Institutional ownership is high at 57%, with several major funds increasing their stakes in the fourth quarter.",
            "banner_image": "https://www.marketbeat.com/logos/talkspace-inc-logo-1200x675.png?v=20230830143339",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.933134"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.848496"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.718475"
                },
                {
                    "topic": "technology",
                    "relevance_score": "0.644896"
                },
                {
                    "topic": "life_sciences",
                    "relevance_score": "0.615243"
                }
            ],
            "overall_sentiment_score": 0.387937,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "TALK",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.382605",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Rating Upgraded by Wall Street Zen",
            "url": "https://www.marketbeat.com/instant-alerts/supernus-pharmaceuticals-nasdaqsupn-stock-rating-upgraded-by-wall-street-zen-2026-02-28/",
            "time_published": "20260228T064002",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Wall Street Zen has upgraded Supernus Pharmaceuticals (NASDAQ:SUPN) from a \"buy\" to a \"strong-buy\" rating, though other analysts have mixed opinions, resulting in a consensus \"Hold\" rating with a $62.17 price target. The company's stock currently trades around $54.73, with recent insider selling activity observed. Supernus Pharmaceuticals specializes in developing and commercializing central nervous system therapies.",
            "banner_image": "https://www.marketbeat.com/logos/supernus-pharmaceuticals-logo-1200x675.jpg",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "financial_markets",
                    "relevance_score": "1.000000"
                },
                {
                    "topic": "life_sciences",
                    "relevance_score": "1.000000"
                },
                {
                    "topic": "earnings",
                    "relevance_score": "0.903658"
                }
            ],
            "overall_sentiment_score": 0.120636,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SUPN",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.132335",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Smith & Wesson Brands (NASDAQ:SWBI) Rating Lowered to Hold at Wall Street Zen",
            "url": "https://www.marketbeat.com/instant-alerts/smith-wesson-brands-nasdaqswbi-rating-lowered-to-hold-at-wall-street-zen-2026-02-28/",
            "time_published": "20260228T063953",
            "authors": [
                "MarketBeat"
            ],
            "summary": "Wall Street Zen has downgraded Smith & Wesson Brands (NASDAQ:SWBI) from \"buy\" to \"hold\", maintaining a consensus \"Hold\" rating with an average price target of $11.00. The company recently surpassed earnings and revenue estimates but experienced a 3.9% year-over-year revenue decline and has thin net margins. Shares are currently trading around $11.90, with institutional investors holding approximately 59% of the stock.",
            "banner_image": "https://www.marketbeat.com/logos/smith--wesson-brands-inc-logo-1200x675.png?v=20240529124156",
            "source": "MarketBeat",
            "category_within_source": "General",
            "source_domain": "MarketBeat",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.938149"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.830933"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.639547"
                }
            ],
            "overall_sentiment_score": 0.030715,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SWBI",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.031260",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "TFS Financial Governance Continuity Puts Dividend Sustainability In The Spotlight",
            "url": "https://simplywall.st/stocks/us/banks/nasdaq-tfsl/tfs-financial/news/tfs-financial-governance-continuity-puts-dividend-sustainabi",
            "time_published": "20260228T063027",
            "authors": [
                "Simply Wall St"
            ],
            "summary": "Shareholders of TFS Financial re-elected directors and approved executive compensation, signaling comfort with current leadership. While this indicates stable governance, questions arise regarding the sustainability of the 8.06% dividend yield given its current coverage by earnings and recent insider selling. TFS Financial's stock has seen positive returns over the past year and three years, and earnings are forecast to grow, potentially supporting future dividend coverage.",
            "banner_image": "https://images.ctfassets.net/n07nr2koi959/6YVpCWgrk0c9DenG6UgW8m/d79e37d527c71a95e08b9ce1071ba986/Image_from_iOS.jpg?fit=thumb&w=64&h=64",
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.894748"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.953700"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.955938"
                }
            ],
            "overall_sentiment_score": 0.145427,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TFSL",
                    "relevance_score": "0.996606",
                    "ticker_sentiment_score": "0.120135",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Hormel Refocuses On Value Added Protein As CTO Leads Tech Shift",
            "url": "https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-hrl/hormel-foods/news/hormel-refocuses-on-value-added-protein-as-cto-leads-tech-sh",
            "time_published": "20260228T063025",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "Hormel Foods (NYSE:HRL) is divesting its whole bird turkey business to concentrate on higher-margin, value-added protein products, reflecting a strategic shift away from commodity-driven categories. The company has also appointed Donald Monk as its first Chief Technology Officer to spearhead its technology and data strategy, signaling a move towards integrating data, automation, and digital tools into its core operations. These actions aim to reshape Hormel's portfolio and internal capabilities for long-term margin improvement, operational efficiency, and a more resilient earnings profile.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.848457"
                },
                {
                    "topic": "mergers_and_acquisitions",
                    "relevance_score": "0.822461"
                },
                {
                    "topic": "retail_wholesale",
                    "relevance_score": "0.718928"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.636284"
                }
            ],
            "overall_sentiment_score": 0.195179,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HRL",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.292946",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KHC",
                    "relevance_score": "0.603890",
                    "ticker_sentiment_score": "0.139952",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSN",
                    "relevance_score": "0.605578",
                    "ticker_sentiment_score": "0.140630",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is It Too Late To Consider Equinix (EQIX) After Its Strong Share Price Momentum?",
            "url": "https://simplywall.st/stocks/us/real-estate/nasdaq-eqix/equinix/news/is-it-too-late-to-consider-equinix-eqix-after-its-strong-sha",
            "time_published": "20260228T063011",
            "authors": [
                "Simply Wall St",
                "Bailey Pemberton"
            ],
            "summary": "Equinix (EQIX) has shown strong share price momentum recently. A Discounted Cash Flow (DCF) analysis suggests it is undervalued by 30.7% at its current price of US$974, estimating an intrinsic value of $1,406 per share. However, its current P/E ratio of 70.91x is higher than the industry average and a \"Fair Ratio\" of 37.88x, indicating it is overvalued by this metric.",
            "banner_image": null,
            "source": "Simply Wall St",
            "category_within_source": "General",
            "source_domain": "Simply Wall St",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.929300"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.803139"
                },
                {
                    "topic": "real_estate",
                    "relevance_score": "0.707985"
                }
            ],
            "overall_sentiment_score": 0.270566,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "EQIX",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.281497",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DLR",
                    "relevance_score": "0.608661",
                    "ticker_sentiment_score": "0.254325",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Duke Energy Stock After Earnings: Safe Utility Or Rate-Cut Winner In Disguise?",
            "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/duke-energy-stock-after-earnings-safe-utility-or-rate-cut-winner-in/68620153",
            "time_published": "20260228T061308",
            "authors": [],
            "summary": "Duke Energy updated Wall Street on its earnings, grid spending, and dividend path, positioning itself as a potential defensive yield in a volatile market. The stock's performance in the next year will largely depend on interest rate cuts, capital spending discipline, and the sustainability of its dividend. While analysts view DUK as a \"bond proxy\" with moderate upside, its predictable cash flows and regulated nature make it suitable for income-focused or risk-averse investors, especially if the Federal Reserve eases rates.",
            "banner_image": null,
            "source": "AD HOC NEWS",
            "category_within_source": "General",
            "source_domain": "AD HOC NEWS",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.923891"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.805838"
                },
                {
                    "topic": "economy_monetary",
                    "relevance_score": "0.837318"
                },
                {
                    "topic": "energy_transportation",
                    "relevance_score": "0.706195"
                }
            ],
            "overall_sentiment_score": 0.249514,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "DUK",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.253729",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "ICE Stock Surges 6.6% With A 5-day Winning Spree On Record Earnings Beat",
            "url": "https://www.trefis.com/data/companies/ICE/no-login-required/j7Ht3gdg/ICE-Stock-Surges-6-6-With-A-5-day-Winning-Spree-On-Record-Earnings-Beat",
            "time_published": "20260228T060026",
            "authors": [],
            "summary": "ICE stock surged 6.6% and recorded a five-day winning streak following an earnings beat. The article indicates this positive performance is due to strong financial results.",
            "banner_image": null,
            "source": "Trefis",
            "category_within_source": "General",
            "source_domain": "Trefis",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.902457"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.715665"
                },
                {
                    "topic": "finance",
                    "relevance_score": "0.637090"
                }
            ],
            "overall_sentiment_score": 0.804612,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ICE",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "0.808809",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "GPN Stock Falls -7.3% With A 5-day Losing Spree On Post-Earnings Doubts",
            "url": "https://www.trefis.com/data/companies/GPN/no-login-required/KfSU22Fc/GPN-Stock-Falls-7-3-With-A-5-day-Losing-Spree-On-Post-Earnings-Doubts",
            "time_published": "20260228T060025",
            "authors": [],
            "summary": "GPN stock experienced a significant drop of 7.3%, extending a five-day losing streak due to skepticism following its latest earnings report. The article title highlights investor doubts regarding the company's recent financial performance.",
            "banner_image": "https://www.trefis.com/tracking/beacon/0.5438532601923242?modelVersion=6938557&activity=MODEL&type=VIEW",
            "source": "Trefis",
            "category_within_source": "General",
            "source_domain": "Trefis",
            "topics": [
                {
                    "topic": "earnings",
                    "relevance_score": "0.914214"
                },
                {
                    "topic": "financial_markets",
                    "relevance_score": "0.803678"
                }
            ],
            "overall_sentiment_score": -0.42779,
            "overall_sentiment_label": "Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "GPN",
                    "relevance_score": "1.000000",
                    "ticker_sentiment_score": "-0.419802",
                    "ticker_sentiment_label": "Bearish"
                }
            ]
        }
    ]
}
